dual C5aR/CXCR1 inhibitors (Dompe)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedual C5aR/CXCR1 inhibitors (Dompe)
Drug Alias NameDF-2297A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 1 antagonistsC5a anaphylatoxin chemotactic receptor antagonists
TargetsC5a anaphylatoxin chemotactic receptorC-X-C motif chemokine receptor 1
Therapy Area/IndicationsInflammationAutoimmune DiseasesReperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDompé farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDompé farmaceutici SPA
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesReperfusion Injury

Other Information

ATC CodeN/A
Related LinksN/A